Announcement of The Shaw Laureates 2026
HONG KONG, May 27, 2026 /PRNewswire/ -- The Shaw Prize in Astronomy…
ADECCO GROUP DIVIDEND 2026: ANNOUNCEMENT OF FINAL TERMS
AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss…
Major shareholder announcement
Pursuant to Section 30 of the Danish Capital Markets Act, ALK (ALKB:DC…
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities
November 14, 2025 17:05 ET | Source: Waldencast plc NEW YORK, Nov.…
SEMI Issues Statement on U.S. H1-B Visa Policy Announcement
MILPITAS, Calif., Sept. 22, 2025 /PRNewswire/ -- SEMI, the industry association serving…
Coloplast A/S – Announcement no. 07/2025 – Coloplast announces new financial ambition towards 2030
In relation to the launch of Coloplast’s new 5-year strategy, Impact4, the company…
A New Eye, A New Era: Bigg Boss 19 Unveils Fiery First Glimpse
A New Eye, A New Era: Bigg Boss 19 Unveils A Fiery…
Clarification on Leadership Announcement: Annette Slyman not to join Life Backup Plan as Chief Operating Officer
July 11, 2025 16:30 ET | Source: Life Backup Plan by Galacxia,…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients](https://i1.wp.com/ml-eu.globenewswire.com/media/NTJlMDkyZjktNGMwNi00N2YyLTkyZmQtZTIwMWJlNzgxOWYyLTEwMTI2MjEtMjAyNS0wNi0xNS1lbg==/tiny/F-Hoffmann-La-Roche-Ltd.png?w=420&resize=420,280&ssl=1 "[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients")
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
After a thorough clinical review, the benefit-risk for the use of Elevidys…
FAIR PLAY MENARINI INTERNATIONAL AWARD, THE 2025 EDITION BEGINS WITH THE ANNOUNCEMENT OF THIS YEAR’S AWARDEES AT CONI
ROME, June 11, 2025 /PRNewswire/ -- The sense of anticipation is increasing,…
